Subscribe to RSS

DOI: 10.1055/s-0044-1788286
APOE Polymorphism, Obstructive Sleep Apnea, and Cognitive Function
Funding Source Dra. Linda M. Ueno-Pardi receives funding from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP, # 2015/14795-0 and 2010/15064-6).
Abstract
Objective Obstructive sleep apnea (OSA) is associated with the apolipoprotein E ε4 polymorphic allele (APOE ε4) and with worse cognitive function. However, the influence of APOE ε4 on cognitive function in patients with moderate-to-severe OSA is controversial. The present study evaluated the influence of APOE ε4 polymorphism and cognitive function in sedentary OSA patients with no other major comorbidities.
Materials and Methods In total, 55 middle-aged patients underwent conventional nocturnal polysomnography, APOE ε4 polymorphism genotyping, cognitive evaluation (attention, inhibitory control, frontal functions, processing speed, and episodic memory), and they filled out the International Physical Activity Questionnaire.
Results Overall, 13 patients had no or mild OSA, and 42 had moderate-to-severe OSA (apnea-hypopnea index [AHI] ≥ 15 events/h of sleep) and APOE ε4 was present in 7.7% and 21.4% of the patients in each group respectively. Among patients with moderate-to-severe OSA, the sleep parameters were similar in the groups of APOE ε4 carriers and noncarriers. Compared with patients with no or mild OSA, the cognitive parameters were worse for processing speed (Digit Symbol Test) and attention (Stroop Color Word Test, SCWT-Part 2) among the patients with moderate-to-severe OSA. The difference was present even after the exclusion of APOE ε4 carriers. Among patients with moderate-to-severe OSA, APOE ε4 carriers presented worse episodic memory, evaluated through the Rey Auditory Verbal Learning Test, than APOE ε4 noncarriers.
Conclusion Moderate-to-severe OSA is associated with poor cognitive function that is further impaired by the presence of APOE ε4 polymorphism.
Publication History
Received: 31 August 2023
Accepted: 05 February 2024
Article published online:
23 July 2024
© 2024. Brazilian Sleep Academy. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Yeghiazarians Y, Jneid H, Tietjens JR. et al. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation 2021; 144 (03) e56-e67
- 2 Somers VK, White DP, Amin R. et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. Circulation 2020; 72: 50-58
- 3 Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353 (19) 2034-2041
- 4 Ayas NT, Taylor CM, Laher I. Cardiovascular consequences of obstructive sleep apnea. Curr Opin Cardiol 2016; 31 (06) 599-605
- 5 Marin JM, Carrizo SJ, Vicente E, Agusti AGN. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365 (9464) 1046-1053
- 6 Vanek J, Prasko J, Genzor S. et al. Obstructive sleep apnea, depression and cognitive impairment. Sleep Med 2020; 72: 50-58 Review
- 7 Bucks RS, Olaithe M, Rosenzweig I, Morrell MJ. Reviewing the relationship between OSA and cognition: Where do we go from here?. Respirology 2017; 22 (07) 1253-1261
- 8 Tkacova R, McNicholas WT, Javorsky M. et al; European Sleep Apnoea Database study collaborators. Nocturnal intermittent hypoxia predicts prevalent hypertension in the European Sleep Apnoea Database cohort study. Eur Respir J 2014; 44 (04) 931-941
- 9 McLaurin J, D'Souza S, Stewart J. et al. Effect of tumor necrosis factor alpha and beta on human oligodendrocytes and neurons in culture. Int J Dev Neurosci 1995; 13 (3-4): 369-381
- 10 Castronovo V, Scifo P, Castellano A. et al. White matter integrity in obstructive sleep apnea before and after treatment. Sleep 2014; 37 (09) 1465-1475
- 11 Torelli F, Moscufo N, Garreffa G. et al. Cognitive profile and brain morphological changes in obstructive sleep apnea. Neuroimage 2011; 54 (02) 787-793
- 12 Ho BL, Tseng PT, Lai CL. et al. Obstructive sleep apnea and cerebral white matter change: a systematic review and meta-analysis. J Neurol 2018; 265 (07) 1643-1653
- 13 Bruin PFC, Bagnato MC. Alterações cognitivas na SAOS. Cognitive impairment in obstructive sleep apnea syndrome. J Bras Pneumol 2010; •••: 1-61
- 14 Legault J, Thompson C, Martineau-Dussault MÈ. et al. Obstructive sleep apnea and cognitive decline: a review of potential vulnerability and protective factors. Brain Sci 2021; 11 (06) 706
- 15 Varvarigou V, Dahabreh IJ, Malhotra A, Kales SN. A review of genetic association studies of obstructive sleep apnea: field synopsis and meta-analysis. Sleep 2011; 34 (11) 1461-1468
- 16 Small BJ, Rosnick CB, Fratiglioni L, Bäckman L. Apolipoprotein E and cognitive performance: a meta-analysis. Psychol Aging 2004; 19 (04) 592-600
- 17 Sun J, Hu J, Tu C, Zhong A, Xu H. Obstructive sleep apnea susceptibility genes in Chinese population: A field synopsis and meta-analysis of genetic association studies. PLoS One 2015; 10 (08) e0135942
- 18 Guerra RS, Goya TT, Silva RF. et al. Exercise training increases metaboreflex control in patients with obstructive sleep apnea. Med Sci Sports Exerc 2019; 51 (03) 426-435
- 19 Ueno-Pardi LM, Souza-Duran FL, Matheus L. et al. Effects of exercise training on brain metabolism and cognitive functioning in sleep apnea. Sci Rep 2022; 12 (01) 9453
- 20 Flaks MK, Yassuda MS, Regina AC. et al. The Short Cognitive Performance Test (SKT): a preliminary study of its psychometric properties in Brazil. Int Psychogeriatr 2006; 18 (01) 121-133
- 21 Wang HK, Fung HC, Hsu WC. et al. Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia. J Neural Transm (Vienna) 2006; 113 (10) 1499-1509
- 22 Matsudo S, Araujo T, Matsudo V. et al. Questionário Internacional de Atividade Física (IPAQ): estudo de validade e reprodutibilidade no Brasil. Revista Brasileira de Atividade Física e Saúde 2001; 6: 5-18
- 23 Cosentino FI, Bosco P, Drago V. et al. The APOE epsilon4 allele increases the risk of impaired spatial working memory in obstructive sleep apnea. Sleep Med 2008; 9 (08) 831-839
- 24 Kadotani H, Kadotani T, Young T. et al. Association between apolipoprotein E epsilon4 and sleep-disordered breathing in adults. JAMA 2001; 285 (22) 2888-2890
- 25 Alvim RO, Freitas SRS, Ferreira NE. et al. APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population. Lipids Health Dis 2010; 9: 128
- 26 Lu Z, Wu X, Jin X, Peng F, Lin J. Apolipoprotein E ɛ2/ɛ3/ɛ4 variant in association with obstructive sleep apnoea and lipid profile: A meta-analysis. J Int Med Res 2016; 44 (01) 3-14
- 27 Xu H, Qian Y, Guan J, Yi H, Yin S. No association between the ApoE ε2 and ε4 alleles and the risk of obstructive sleep apnea: A systematic review and meta-analysis. Biomed Rep 2015; 3 (03) 313-318
- 28 Beebe DW, Groesz L, Wells C, Nichols A, McGee K. The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case-controlled data. Sleep 2003; 26 (03) 298-307
- 29 Macey PM, Kumar R, Woo MA, Valladares EM, Yan-Go FL, Harper RM. Brain structural changes in obstructive sleep apnea. Sleep 2008; 31 (07) 967-977
- 30 Macey PM, Kumar R, Woo MA, Yan-Go FL, Harper RM. Heart rate responses to autonomic challenges in obstructive sleep apnea. PLoS One 2013; 8 (10) e76631
- 31 Yaouhi K, Bertran F, Clochon P. et al. A combined neuropsychological and brain imaging study of obstructive sleep apnea. J Sleep Res 2009; 18 (01) 36-48
- 32 Beebe DW, Gozal D. Obstructive sleep apnea and the prefrontal cortex: towards a comprehensive model linking nocturnal upper airway obstruction to daytime cognitive and behavioral deficits. J Sleep Res 2002; 11 (01) 1-16
- 33 Zimmerman ME, Aloia MS. A review of neuroimaging in obstructive sleep apnea. J Clin Sleep Med 2006; 2 (04) 461-471
- 34 Siccoli MM, Pepperell JCT, Kohler M, Craig SE, Davies RJO, Stradling JR. Effects of continuous positive airway pressure on quality of life in patients with moderate to severe obstructive sleep apnea: data from a randomized controlled trial. Sleep 2008; 31 (11) 1551-1558
- 35 Karimi M, Hedner J, Häbel H, Nerman O, Grote L. Sleep apnea-related risk of motor vehicle accidents is reduced by continuous positive airway pressure: Swedish Traffic Accident Registry data. Sleep 2015; 38 (03) 341-349
- 36 Rajaratnam SMW, Howard ME, Grunstein RR. Sleep loss and circadian disruption in shift work: health burden and management. Med J Aust 2013; 199 (08) S11-S15
- 37 Mahley RW, Rall Jr SC. Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 2000; 1: 507-537
- 38 Laws SM, Hone E, Gandy S, Martins RN. Expanding the association between the APOE gene and the risk of Alzheimer's disease: possible roles for APOE promoter polymorphisms and alterations in APOE transcription. J Neurochem 2003; 84 (06) 1215-1236
- 39 Raichlen DA, Alexander GE. Exercise, APOE genotype, and the evolution of the human lifespan. Trends Neurosci 2014; 37 (05) 247-255
- 40 Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes–systematic overview of prospective observational studies. Diabetologia 2005; 48 (12) 2460-2469
- 41 Chatterjee S, Peters SAE, Woodward M. et al. Type 2 diabetes as a risk factor for dementia in women compared with men: A pooled analysis of 2.3 million people comprising more than 100,000 cases of dementia. Diabetes Care 2016; 39 (02) 300-307
- 42 Qu Y, Hu HY, Ou YN. et al. Association of body mass index with risk of cognitive impairment and dementia: A systematic review and meta-analysis of prospective studies. Neurosci Biobehav Rev 2020; 115: 189-198
- 43 Kalmijn S, van Boxtel MP, Verschuren MW, Jolles J, Launer LJ. Cigarette smoking and alcohol consumption in relation to cognitive performance in middle age. Am J Epidemiol 2002; 156 (10) 936-944
- 44 Richards M, Jarvis MJ, Thompson N, Wadsworth ME. Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am J Public Health 2003; 93 (06) 994-998
- 45 Conti AA, McLean L, Tolomeo S, Steele JD, Baldacchino A. Chronic tobacco smoking and neuropsychological impairments: A systematic review and meta-analysis. Neurosci Biobehav Rev 2019; 96: 143-154
- 46 Erickson KI, Hillman C, Stillman CM. et al; FOR 2018 PHYSICAL ACTIVITY GUIDELINES ADVISORY COMMITTEE*. Physical Activity, Cognition, and Brain Outcomes: A Review of the 2018 Physical Activity Guidelines. Med Sci Sports Exerc 2019; 51 (06) 1242-1251
- 47 Nikodemova M, Finn L, Mignot E, Salzieder N, Peppard PE. Association of sleep disordered breathing and cognitive deficit in APOE ε4 carriers. Sleep 2013; 36 (06) 873-880
- 48 Pellegrino R, Mazzotti DR, Guindalini C, Santos-Silva R, Bittencourt LR, Tufik S. Apolipoprotein E polymorphisms and sleep quality in obstructive sleep apnea syndrome. Clin Chim Acta 2011; 412 (23-24): 2223-2227
- 49 Xie L, Kang H, Xu Q. et al. Sleep drives metabolite clearance from the adult brain. Science 2013; 342 (6156) 373-377
- 50 Roh JH, Huang Y, Bero AW. et al. Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer's disease pathology. Sci Transl Med 2012; 4 (150) 150ra122
- 51 Lim ASP, Yu L, Kowgier M, Schneider JA, Buchman AS, Bennett DA. Modification of the relationship of the apolipoprotein E ε4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleep. JAMA Neurol 2013; 70 (12) 1544-1551